Meridian Bioscience - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Meridian Bioscience M&A Summary

Meridian Bioscience has acquired 12 companies of its own, including 4 in the last 5 years. A total of 2 acquisitions came from private equity firms.

Meridian Bioscience’s largest acquisition to date was in 2019, when it acquired GenePOC - State-of-the-Art Molecular Diagnostics Platform for $120M. Meridian Bioscience has acquired in 6 different US states, and 4 countries. The Company’s most targeted sectors include life science (46%) and medical products (46%).

Meridian Bioscience Ownership

Who owns Meridian Bioscience?

Meridian Bioscience is owned by SD BioSensor and SJL Partners. It was acquired on July 7, 2022.

Is Meridian Bioscience PE-backed?

Yes. Meridian Bioscience is owned by private equity investors SD BioSensor and SJL Partners.

Meridian Bioscience Business Overview

Where is Meridian Bioscience headquartered?

Meridian Bioscience is headquartered in Cincinnati, Ohio.

What is Meridian Bioscience’s revenue?

Meridian Bioscience disclosed revenue of 318M USD for 2021 and 254M USD for 2020.

How many employees does Meridian Bioscience have?

Meridian Bioscience has 702 employees.

What sector is Meridian Bioscience in?

Meridian Bioscience is a life science company.

When was Meridian Bioscience founded?

Meridian Bioscience was founded in 1976.

M&A Summary

  • M&A Total Activity11
    • M&A Buy Activity11
  • Total Sectors Invested 3
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 6
  • M&A Advisors 2

Meridian Bioscience

Meridian Bioscience, Inc.

3471 River Hills Drive,
Cincinnati, Ohio 45244
United States,
(513) 271-3700
www.meridianbioscience.com

Meridian is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Meridian was founded in 1976 and is based in Cincinnati, Ohio.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # 8 1 1 1 - - 11
vol $158M $49M $20M $227M
Sell (0.0/yr) # - - - - - - 0
  11

Most Recent M&A

Company Date Value Type
Euprotein, Inc. 2022-05-02 - Add-on Acquisition
North Brunswick, New Jersey · www.euprotein.com
Otsuka America Pharmaceutical - North American BreathTek business 2021-07-23 20M USD Divestiture
Princeton, New Jersey
Exalenz Bioscience Ltd. 2020-02-19 49M USD Add-on Acquisition
Modiin, Israel · www.exalenz.com
GenePOC, Inc. - State-of-the-Art Molecular Diagnostics Platform 2019-04-30 120M USD Divestiture
Québec, Quebec
Magellan Biosciences, Inc. 2016-03-24 - Add-on Acquisition
Chelmsford, Massachusetts · www.magellanbio.com
Magellan Diagnostics, Inc. 2016-03-24 - Divestiture
North Billerica, Massachusetts · www.magellanbio.com
Bioline Reagents Ltd. 2010-07-20 23M USD Add-on Acquisition
London, United Kingdom · www.bioline.com
Vybion - Recombinant Protein Technologies 2008-05-13 - Divestiture
, United States
O.E.M. Concepts, Inc. 2005-02-01 6M USD Add-on Acquisition
Saco, Michigan · www.oemconcepts.com
Viral Antigens, Inc. 2000-09-27 9M USD Add-on Acquisition
Memphis, Tennessee
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Magellan Biosciences, Inc. 2016-03-24 Magellan Diagnostics, Inc. 2016-03-24 1
Chelmsford, Massachusetts · www.magellanbio.com North Billerica, Massachusetts · www.magellanbio.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (45%) 169M (74%) - -
Medical Products 5 (45%) 58M (26%) - -
Machinery 1 (9%) - - -
Total 11 $227M - -

By Geo

State/Country Buy Value Sell Value
United States 8 35M - -
  New Jersey 2 20M - -
  Massachusetts 2 - - -
  Utah 1 - - -
  Tennessee 1 9M - -
  Michigan 1 6M - -
Canada 1 120M - -
  Quebec 1 120M - -
Israel 1 49M - -
United Kingdom 1 23M - -
Domestic 8 (73%) 35M (15%) - -
Cross-border 3 (27%) 192M (85%) - -
Total 11 $227M - -

Top M&A Advisors

Financial Deals
Rothschild Global Advisory
1
Legal Deals
Amit, Pollak, Matalon & Co. (APM & Co.)
1

Deal Values

buy # Total
$100M to $1B 1 $120M
< $100M 5 $107M
TOTAL $227M
Largest GenePOC, Inc. - State-of-the-Art Molecular Diagnostics Platform
$120M (2019-04-30)

M&A Connections

Deals
Acquired from
Investor(s)
9%
1 (9%)
Strategic(s)
36%
4 (36%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.